180 related articles for article (PubMed ID: 10760365)
1. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
Keck BJ; Lakoski JM
Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
Alper RH; Nelson DL
Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
[TBL] [Abstract][Full Text] [Related]
3. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
[TBL] [Abstract][Full Text] [Related]
4. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
Vinod KY; Subhash MN; Srinivas BN
Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
[TBL] [Abstract][Full Text] [Related]
5. Alkylation of [3H]8-OH-DPAT binding sites in rat cerebral cortex and hippocampus.
Nénonéné EK; Radja F; Carli M; van Gelder NM; Afkhami-Dastjerdian S; Reader TA
Neurochem Res; 1996 Feb; 21(2):167-76. PubMed ID: 9182242
[TBL] [Abstract][Full Text] [Related]
6. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
Keck BJ; Lakoski JM
Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
8. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
Sánchez C; Mørk A
Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
[TBL] [Abstract][Full Text] [Related]
9. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
10. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
Pinto W; Battaglia G
Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
[TBL] [Abstract][Full Text] [Related]
11. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
12. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
Keck BJ; Lakoski JM
Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
[TBL] [Abstract][Full Text] [Related]
13. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain.
Duncan MJ; Hensler JG
Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
[TBL] [Abstract][Full Text] [Related]
16. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
Koek W; Assié MB; Zernig G; France CP
Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
[TBL] [Abstract][Full Text] [Related]
17. Age-related assessment of central 5-HT1A receptors following irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Keck J; Lakoski JM
Brain Res; 1996 Jul; 728(1):130-4. PubMed ID: 8864308
[TBL] [Abstract][Full Text] [Related]
18. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
Yocca FD; Iben L; Meller E
Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
[TBL] [Abstract][Full Text] [Related]
19. Effects of aging on 5-HT(1A) receptors and their functional response to 5-HT(1a) agonist in the living brain: PET study with [carbonyl-(11)C]WAY-100635 in conscious monkeys.
Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Harada N
Synapse; 2001 Dec; 42(4):242-51. PubMed ID: 11746722
[TBL] [Abstract][Full Text] [Related]
20. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
Zahorodna A; Tokarski K; Bijak M
Eur J Pharmacol; 2002 May; 443(1-3):51-7. PubMed ID: 12044792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
